MedTrace Logo

Caudal Block With Bupivacaine and Dexmedetomidine Versus TAP Block With Bupivacaine Alone for Postoperative Analgesia in Pediatric Undergoing Infraumbical Surgeries

NCT06183073 · Status: RECRUITING · Phase: PHASE2 · Type: INTERVENTIONAL · Enrollment: 90

Last updated 2023-12-27

No results posted yet for this study

Summary

Acute pain management for pediatric surgical patients intraoperatively and postoperatively is important for their comfort and psychological impact. Children aged 3-9 years old are included in the study and are divided randomly into two groups (45 children in each):

Group D: Caudal block with bupivacaine 0.25% in a dose of (1 ml / kg) and dexmedetomidine 1μg/ kg.

Group T: TAP block with bupivacaine 0.25% in a dose of (0.5 ml / kg).

Conditions

  • Postoperative Pain

Interventions

PROCEDURE

caudal block

bupivacaine 0.25% in a dose of (1 ml / kg)

DRUG

Dexmedetomidine

dexmedetomidine 1μg/ kg.

PROCEDURE

TAP

analgesia

DRUG

Bupivacain

bupivacaine 0.25% in a dose of (0.5 ml / kg

Sponsors & Collaborators

  • Sohag University

    lead OTHER

Principal Investigators

  • Fouad I Soliman, MD · Sohag University

Study Design

Allocation
RANDOMIZED
Purpose
HEALTH_SERVICES_RESEARCH
Masking
QUADRUPLE
Model
PARALLEL

Eligibility

Min Age
3 Years
Max Age
9 Years
Sex
ALL
Healthy Volunteers
Yes

Timeline & Regulatory

Start
2023-04-02
Primary Completion
2024-01-14
Completion
2024-02-01

Countries

  • Egypt

Study Locations

More Related Trials

Read the full study record

This page highlights key information. For complete eligibility criteria, study locations, investigator contacts, and the full protocol, visit the original record on ClinicalTrials.gov.

View NCT06183073 on ClinicalTrials.gov